Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

NCT00655226 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT00655226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00655226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2008
Completion date
May 31, 2010
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, depressive disorder, major, hepatitis c, hiv infections